Global Cancer Targeted Therapy Market Size, Status and Forecast 2022


#1068237

94pages

QYResearch

$ 3300

In Stock

This report studies the global Cancer Targeted Therapy market, analyzes and researches the Cancer Targeted Therapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Advaxis
Bind Therapeutics
Boehringer Ingelheim
Bristol Mayer Squibb
Celldex Therapeutics
Dendreon Corporation
Eli Lily
GalaxoSmithKline
Galena Biopharma
Genetech
ImmunoCellular Therapeutics
ImmunoGen
Inovio Pharmaceuticals
Johnson & Johnson
NeoStem Oncology
NewLink Genetics
Northwest Biotherapeutics
Merck
Novartis
Peregrine Pharmaceuticals
Pfizer
Roche
Sanofi
Seattle Genetics
Teva
...

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Cancer Targeted Therapy can be split into
Tumor Antigens As Targets of Antibodies
Development of Antibodies for Clinical Purposes
Complement Dependent Cytotoxicity (CDC)
Signal Transduction Changes

Market segment by Application, Cancer Targeted Therapy can be split into
Hospital
Clinic
Other

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

Global Cancer Targeted Therapy Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Targeted Therapy
1.1 Cancer Targeted Therapy Market Overview
1.1.1 Cancer Targeted Therapy Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Targeted Therapy Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Targeted Therapy Market by Type
1.3.1 Tumor Antigens As Targets of Antibodies
1.3.2 Development of Antibodies for Clinical Purposes
1.3.3 Complement Dependent Cytotoxicity (CDC)
1.3.4 Signal Transduction Changes
1.4 Cancer Targeted Therapy Market by End Users/Application
1.4.1 Hospital
1.4.2 Clinic
1.4.3 Other

2 Global Cancer Targeted Therapy Competition Analysis by Players
2.1 Cancer Targeted Therapy Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Advaxis
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Bind Therapeutics
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Bristol Mayer Squibb
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Celldex Therapeutics
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Dendreon Corporation
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eli Lily
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 GalaxoSmithKline
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Galena Biopharma
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Genetech
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Targeted Therapy Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 ImmunoCellular Therapeutics
3.12 ImmunoGen
3.13 Inovio Pharmaceuticals
3.14 Johnson & Johnson
3.15 NeoStem Oncology
3.16 NewLink Genetics
3.17 Northwest Biotherapeutics
3.18 Merck
3.19 Novartis
3.20 Peregrine Pharmaceuticals
3.21 Pfizer
3.22 Roche
3.23 Sanofi
3.24 Seattle Genetics
3.25 Teva

4 Global Cancer Targeted Therapy Market Size by Type and Application (2012-2017)
4.1 Global Cancer Targeted Therapy Market Size by Type (2012-2017)
4.2 Global Cancer Targeted Therapy Market Size by Application (2012-2017)
4.3 Potential Application of Cancer Targeted Therapy in Future
4.4 Top Consumer/End Users of Cancer Targeted Therapy

5 United States Cancer Targeted Therapy Development Status and Outlook
5.1 United States Cancer Targeted Therapy Market Size (2012-2017)
5.2 United States Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

6 EU Cancer Targeted Therapy Development Status and Outlook
6.1 EU Cancer Targeted Therapy Market Size (2012-2017)
6.2 EU Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

7 Japan Cancer Targeted Therapy Development Status and Outlook
7.1 Japan Cancer Targeted Therapy Market Size (2012-2017)
7.2 Japan Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

8 China Cancer Targeted Therapy Development Status and Outlook
8.1 China Cancer Targeted Therapy Market Size (2012-2017)
8.2 China Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

9 India Cancer Targeted Therapy Development Status and Outlook
9.1 India Cancer Targeted Therapy Market Size (2012-2017)
9.2 India Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Cancer Targeted Therapy Development Status and Outlook
10.1 Southeast Asia Cancer Targeted Therapy Market Size (2012-2017)
10.2 Southeast Asia Cancer Targeted Therapy Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Cancer Targeted Therapy Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Targeted Therapy Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Targeted Therapy Market Size (Value) by Type (2017-2022)
11.3 Global Cancer Targeted Therapy Market Size by Application (2017-2022)

12 Cancer Targeted Therapy Market Dynamics
12.1 Cancer Targeted Therapy Market Opportunities
12.2 Cancer Targeted Therapy Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Targeted Therapy Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Targeted Therapy Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


List of Tables and Figures

Figure Cancer Targeted Therapy Product Scope
Figure Global Cancer Targeted Therapy Market Size (Million USD) (2012-2017)
Table Global Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Targeted Therapy Market Share by Regions in 2016
Figure United States Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Targeted Therapy Market Share by Type in 2016
Figure Tumor Antigens As Targets of Antibodies Market Size (Million USD) and Growth Rate (2012-2017)
Figure Development of Antibodies for Clinical Purposes Market Size (Million USD) and Growth Rate (2012-2017)
Figure Complement Dependent Cytotoxicity (CDC) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Signal Transduction Changes Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Cancer Targeted Therapy Market Share by Application in 2016
Figure Cancer Targeted Therapy Market Size (Million USD) and Growth Rate in Hospital (2012-2017)
Figure Cancer Targeted Therapy Market Size (Million USD) and Growth Rate in Clinic (2012-2017)
Figure Cancer Targeted Therapy Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Cancer Targeted Therapy Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Targeted Therapy Market Size Share by Players in 2016
Figure Cancer Targeted Therapy Market Size Share by Players in 2017
Table Advaxis Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Advaxis (2012-2017)
Figure Advaxis Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Bind Therapeutics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Bind Therapeutics (2012-2017)
Figure Bind Therapeutics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Boehringer Ingelheim Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)
Figure Boehringer Ingelheim Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Bristol Mayer Squibb Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Bristol Mayer Squibb (2012-2017)
Figure Bristol Mayer Squibb Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Celldex Therapeutics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Celldex Therapeutics (2012-2017)
Figure Celldex Therapeutics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Dendreon Corporation Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Dendreon Corporation (2012-2017)
Figure Dendreon Corporation Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Eli Lily Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Eli Lily (2012-2017)
Figure Eli Lily Cancer Targeted Therapy Business Revenue Market Share in 2016
Table GalaxoSmithKline Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of GalaxoSmithKline (2012-2017)
Figure GalaxoSmithKline Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Galena Biopharma Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Galena Biopharma (2012-2017)
Figure Galena Biopharma Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Genetech Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Genetech (2012-2017)
Figure Genetech Cancer Targeted Therapy Business Revenue Market Share in 2016
Table ImmunoCellular Therapeutics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of ImmunoCellular Therapeutics (2012-2017)
Figure ImmunoCellular Therapeutics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table ImmunoGen Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of ImmunoGen (2012-2017)
Figure ImmunoGen Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Inovio Pharmaceuticals Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Inovio Pharmaceuticals (2012-2017)
Figure Inovio Pharmaceuticals Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Cancer Targeted Therapy Business Revenue Market Share in 2016
Table NeoStem Oncology Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of NeoStem Oncology (2012-2017)
Figure NeoStem Oncology Cancer Targeted Therapy Business Revenue Market Share in 2016
Table NewLink Genetics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of NewLink Genetics (2012-2017)
Figure NewLink Genetics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Northwest Biotherapeutics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Northwest Biotherapeutics (2012-2017)
Figure Northwest Biotherapeutics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Merck Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Merck (2012-2017)
Figure Merck Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Peregrine Pharmaceuticals Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Peregrine Pharmaceuticals (2012-2017)
Figure Peregrine Pharmaceuticals Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Roche Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Roche (2012-2017)
Figure Roche Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Seattle Genetics Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Seattle Genetics (2012-2017)
Figure Seattle Genetics Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Teva Basic Information List
Table Cancer Targeted Therapy Business Revenue (Million USD) of Teva (2012-2017)
Figure Teva Cancer Targeted Therapy Business Revenue Market Share in 2016
Table Global Cancer Targeted Therapy Market Size (Million USD) by Type (2012-2017)
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2012
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2013
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2014
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2015
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2016
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2017
Table Global Cancer Targeted Therapy Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2012
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2013
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2014
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2015
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2016
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Targeted Therapy
Figure United States Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Targeted Therapy Market Size Share by Players in 2016
Figure United States Cancer Targeted Therapy Market Size Share by Players in 2017
Figure EU Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Targeted Therapy Market Size Share by Players in 2016
Figure EU Cancer Targeted Therapy Market Size Share by Players in 2017
Figure Japan Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Targeted Therapy Market Size Share by Players in 2016
Figure Japan Cancer Targeted Therapy Market Size Share by Players in 2017
Figure China Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Targeted Therapy Market Size Share by Players in 2016
Figure China Cancer Targeted Therapy Market Size Share by Players in 2017
Figure India Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Targeted Therapy Market Size Share by Players in 2016
Figure India Cancer Targeted Therapy Market Size Share by Players in 2017
Figure Southeast Asia Cancer Targeted Therapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Targeted Therapy Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Targeted Therapy Market Size Share by Players in 2016
Figure Southeast Asia Cancer Targeted Therapy Market Size Share by Players in 2017
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Targeted Therapy Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Targeted Therapy Market Size Share by Regions in 2017
Figure Global Cancer Targeted Therapy Market Size Share by Regions in 2022
Figure United States Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Targeted Therapy Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Targeted Therapy Market Size (Million USD) by Type (2017-2022)
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2017
Figure Global Cancer Targeted Therapy Market Size Share by Type in 2022
Table Global Cancer Targeted Therapy Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2017
Figure Global Cancer Targeted Therapy Market Size (Million USD) by Application in 2022